HLA-B*15:02 is a genetic marker that, when present, can lead to severe skin reactions like Stevens-Johnson syndrome upon taking the epilepsy drug carbamazepine. As a health economist, I must argue that a national screening policy for it in India would be a misallocation of scarce resources, as the prevalence is highly variable and concentrated in specific communities, unlike the uniform risk assumed in the question. My own son's college fees are a constant calculation, and I've seen how blanket policies drain funds from local clinics that could use them for more common ailments. We must target screening, not decree it from Delhi, because a gene in some Asians does not mean a risk for all of us.
#life#career
Jump in to reply — no account needed.